Tacrolimus preloading in renal transplantation from live donors
نویسندگان
چکیده
منابع مشابه
Tacrolimus in renal transplantation.
The early studies with tacrolimus. from 1989 through 1991, included a pilot series, a small randomized trial, and a larger nonrandomized group. I.3.4 When the outcome of these patients was compared with that in a roughly concurrent (although somewhat less challenging) group of cyclosporine (CyA)-treated patients, equivalent patient and graft survival rates were seen. However, improved secondary...
متن کاملLive donors in liver transplantation.
Living donor liver transplantation (LDLT) has been controversial since its inception. Begun in response to deceased donor organ shortage and waiting list mortality, LDLT was initiated in 1989 in children, grew rapidly after its first general application in adults in the United States in 1998, and has declined since 2001. There are significant risks to the living donor, including the risk of dea...
متن کاملRenal Transplantation from Elderly Living Donors
Acceptance of elderly living kidney donors remains controversial due to the higher incidence of comorbidity and greater risk of postoperative complications. This is a review of publications in the English language between 2000 and 2013 about renal transplantation from elderly living donors to determine trends and effects of donation, and the outcomes of such transplantation. The last decade wit...
متن کاملRenal Transplantation from Expanded Criteria Donors
The 21st century has come as an era of chronic diseases including chronic kidney diseases. Treatment at the end stage of kidney failure involves replacing the lost functions of kidneys by dialysis or by a kidney transplant. The end stage renal disease (ESRD) population is increasing worldwide. The National Kidney Foundation says that “rates of chronic kidney disease (CKD) in the United States h...
متن کاملTacrolimus nephrotoxicity after renal transplantation.
THIS study describes the clinical profile of tacrolimus (Tac) nephrotoxicity after renal transplantation. Tac was given initially as a 0,075 to 0.1 mg/kg/day IV continuous infusion and then orally at 0.15 mglkg twice daily. Patients were selected based on a rising serum creatinine. normal ultrasound, and absence of rejection on biopsy, leading to a reduction in Tac dosage and fall in creatinine...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Surgery
سال: 2012
ISSN: 1743-9191
DOI: 10.1016/j.ijsu.2012.06.447